Floatz logo

cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc

Advanced Malignant Solid Neoplasm

Tianhong Liprotein_peptidePhase 1/2Dormant
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
11/ 100
Competitive Position
81/ 100

Competitive context

124 Active assets in the Advanced Malignant Solid Neoplasm cohort.

Asset / SponsorPhaseRating
Palbociclib
National Cancer Institute (NCI)
Phase 2BB
Olaparib
National Cancer Institute (NCI)
Phase 2BB
Nivolumab
National Cancer Institute (NCI)
Phase 2BB
Carboplatin
OHSU Knight Cancer Institute
Phase 2B
Vinorelbine
OHSU Knight Cancer Institute
Phase 2B

View all 50 →

Same molecule, other indications

cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc is also rated in:

acute graft versus host diseaseDormant
D
Indicative ·
30 / 100
View asset →
acute myeloid leukemiaDormant
D
Indicative ·
30 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →